Tom Partridge completed his undergraduate biotechnology studies in 2011 at the University of Queensland in Brisbane, Australia. During his final year he investigated the role of SerpinB2 in lentiviral infections in vivo under the supervision of Prof. Andreas Suhrbier at the Queensland Institute of Medical Research. In 2012, he arrived in Oxford to pursue a DPhil under the supervision of Prof. Persephone Borrow and Prof. Benedikt Kessler. During his PhD, he studied the role of dendritic cells in determining the breadth and epitope specificity of CD8+ T cells during acute HIV-1 infection. In 2017 he continued as a Postdoctoral Scientist in the group of Prof Persephone Borrow, working on antigen presentation, extracellular vesicles, T cell responses and discovery of novel immune targets to inform HIV-1 vaccine design.